BridgeMD
New treatment option for Lung Nodules
Official title Bronchoscopic Navigation Robot-guided Dye Marking-assisted Thoracoscopic Pulmonary Nodule Resection
ClinicalTrials.gov ID: NCT06821451
What this study is testing
- What it's testing
- With the widespread use of low-dose spiral CT screening for the lungs, an increasing number of small nodules are being detected, and surgical resection is the preferred method for clinical intervention of pulmonary nodules. Staining localization can assist surgeons in accurately locating pulmonary nodules during surgery, achieving complete resection of the nodules while minimizing the resection area, thereby optimizing surgical outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Aged 18-80 years, regardless of gender;
- Peripheral pulmonary nodules, planned for single lesion non-anatomical sublobar resection via thoracoscopic assistance after preoperative discussion;
- Preoperative assessment indicates that the pulmonary nodules cannot be localized through visual inspection or palpation;
- Patients are able to understand the purpose of the trial, have good compliance with examinations and follow-ups, and voluntarily participate in the...
You likely can't join if
- Patients who meet any of the following criteria will be excluded from this study: \- Surgical contraindications that do not meet surgical tolerance...
- Contraindications for bronchoscopy, including: active massive hemoptysis; recent myocardial infarction or unstable angina; severe hypertension and...
- Female patients who are breastfeeding, pregnant, or trying to conceive;
- Patients with electromagnetic active implantable devices;
- Participants allergic to indocyanine green or anesthetics; or with a history of multiple severe allergies or hereditary allergies;
- Participation in drug clinical trials in the past 3 months, or currently participating, or participation in other medical device clinical trials...
See the full eligibility criteria
- Aged 18-80 years, regardless of gender;
- Peripheral pulmonary nodules, planned for single lesion non-anatomical sublobar resection via thoracoscopic assistance after preoperative discussion;
- Preoperative assessment indicates that the pulmonary nodules cannot be localized through visual inspection or palpation;
- Patients are able to understand the purpose of the trial, have good compliance with examinations and follow-ups, and voluntarily participate in the clinical trial by signing an informed consent form.
- Patients who meet any of the following criteria will be excluded from this study: \- Surgical contraindications that do not meet surgical tolerance standards: fulfilling one major criterion and/or two or more minor...
- Contraindications for bronchoscopy, including: active massive hemoptysis; recent myocardial infarction or unstable angina; severe hypertension and arrhythmias; uncorrectable bleeding tendencies (such as severe...
- Female patients who are breastfeeding, pregnant, or trying to conceive;
- Patients with electromagnetic active implantable devices;
- Participants allergic to indocyanine green or anesthetics; or with a history of multiple severe allergies or hereditary allergies;
- Participation in drug clinical trials in the past 3 months, or currently participating, or participation in other medical device clinical trials within the past 30 days;
- Other conditions deemed unsuitable for participation in this clinical trial by the investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.